Barclays
RGEN icon

Barclays’s Repligen RGEN Stock Holding History

Barclays’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$2.67M – 5602
2025
Q3 		$2.67M Sell
20,000
-60,000
-75% -$7.29M ﹤0.01% 2658
2025
Q2 		$9.95M Buy
80,000
+10,000
+14% +$1.27M ﹤0.01% 1589
2025
Q1 		$8.91M Buy
70,000
+50,000
+250% +$7.7M ﹤0.01% 1488
2024
Q4 		$2.88M Buy
+20,000
New +$2.87M ﹤0.01% 2616
2017
Q3 		– Sell
-40,000
Closed -$1.66M – 7008
2017
Q2 		$1.66M Hold
40,000
– – ﹤0.01% 2419
2017
Q1 		$1.41M Buy
+40,000
New +$1.27M ﹤0.01% 2415

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Barclays's RGEN Position: Q1 2026 in Review

Barclays increased its Repligen (RGEN) stake by 22% in Q1 2026, buying an estimated $4.87M and bringing the position to 194,016 shares worth $22.9M. The position accounts for 0.01% of the portfolio, ranked #1038.

Barclays first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.3M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Barclays held 194,016 shares of Repligen worth $22.9M as of Q1 2026.
  • Barclays bought 34,864 Repligen shares in Q1 2026, an estimated $4.87M.
  • Repligen made up 0.01% of Barclays's portfolio in Q1 2026, its #1038 holding.
  • Barclays first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Repligen position peaked at $34.3M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.